This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.
Web www.patentalert.com
< INGAP protein involved in pancreatic islet neogenesis
< Modular targeted liposomal delivery system
> Metal-containing compositions, preparations and uses
> Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications and preparations
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT